Ruping Shao
Impact in
- Cancer Research top 10%
- NF-κB Signaling Pathways
- Oncology top 5%
Papers in
-
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 3
- Oncology 8
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Mien‐Chie Hung (15 shared papers)Chun Li (4 shared papers)Weiya Xia (6 shared papers)Jian You (1 shared paper)Sanjay Gupta (1 shared paper)Xin Wei (1 shared paper)Gan Liang (1 shared paper)Binhua P. Zhou (2 shared papers)
- Journals
- Oncogene (4 papers)Oncotarget (3 papers)Scientific Reports (2 papers)Cancer Research (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Ruping Shao
33 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 224
- Oncology 396
- Biomaterials 211
- Molecular Biology 747
- Immunology 188
Countries citing papers authored by Ruping Shao
This map shows the geographic impact of Ruping Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruping Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruping Shao more than expected).
Fields of papers citing papers by Ruping Shao
This network shows the impact of papers produced by Ruping Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruping Shao. The network helps show where Ruping Shao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruping Shao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 254 | |
| 2 | 2000 | 141 | |
| 3 | 2010 | 133 | |
| 4 | 2015 | 129 | |
| 5 | 1997 | 101 | |
| 6 | 1999 | 84 | |
| 7 | E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. | 2000 | 82 |
| 8 | 1997 | 64 | |
| 9 | 2004 | 53 | |
| 10 | 2007 | 42 | |
| 11 | 2001 | 40 | |
| 12 | Inhibition of cancer cell growth by BRCA2. | 2002 | 37 |
| 13 | p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. | 2001 | 32 |
| 14 | E1A inhibition of radiation-induced NF-kappaB activity through suppression of IKK activity and IkappaB degradation, independent of Akt activation. | 2001 | 30 |
| 15 | 2007 | 28 | |
| 16 | 2009 | 26 | |
| 17 | Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression. | 2000 | 26 |
| 18 | 2018 | 21 | |
| 19 | 2016 | 21 | |
| 20 | 2017 | 21 |
About Ruping Shao
Ruping Shao is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Cancer Research, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer Research and Treatments (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers), NF-κB Signaling Pathways (3 papers), RNA modifications and cancer (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (224 citations), Oncology (396 citations), Biomaterials (211 citations), Molecular Biology (747 citations) and Immunology (188 citations). Ruping Shao has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Mien‐Chie Hung, Chun Li, Weiya Xia, Jian You, Sanjay Gupta, Xin Wei, Gan Liang, Binhua P. Zhou, J. T. Markert and Paul J. Chiao. Their work appears in journals such as Oncogene, Oncotarget, Scientific Reports, Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.